Date Name Title Filing Type Shares Traded Price Total Held
Feb 11, 2014
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 11,475 $325.10 103,275
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 400 $20.52 103,451
Sep 08, 2011
SVP Finance and Admin CFO Trea
SVP Finance and Admin CFO Trea Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 26,000 $11.64 103,734
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 100 $20.50 103,851
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 500 $20.44 103,951
May 20, 2013
SVP Finance and Admin CFO and
SVP Finance and Admin CFO and Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 806 $266.64 104,015
Aug 21, 2020
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 200 $608.15 104,215
Nov 20, 2012
SVP Res and Devel Sciences
SVP Res and Devel Sciences Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 37,500 $16.80 104,219
Aug 21, 2020
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 9,663 $605.04 104,415
Aug 20, 2020
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 703 $619.29 104,415

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.